Core Insights - Intelligent Bio Solutions Inc. (INBS) is set to receive its sixth patent in the U.S., enhancing its intellectual property portfolio related to its Intelligent Fingerprinting Drug Testing Solution [1][2] - The patent will protect INBS's lateral flow technology, crucial for its market entry strategy in the U.S. drug screening market [2][3] - The demand for non-invasive drug testing solutions is increasing as industries focus on workplace safety and compliance, positioning INBS favorably for market transformation [3] Company Overview - Intelligent Bio Solutions Inc. specializes in rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat [5] - The system screens for commonly used drugs in the workplace, including opiates, cocaine, methamphetamine, and cannabis, with results available in under ten minutes [5] - Current customer segments outside the U.S. include construction, manufacturing, transport, drug treatment organizations, and coroners [5]
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant